Showing posts with label 2011. Show all posts
Showing posts with label 2011. Show all posts

Wednesday, January 10, 2024

NOT GOOD: 2011 Study reports that Ivermectin destroys sperm function--significant reduction in sperm counts and sperm motility on patients tested over an 11-month period

Here is the study.   

Effects of Ivermectin therapy on the sperm functions of Nigerian onchocerciasis patients, Idonije O.Ba ., Asika E.Cb ., Okhiai, Oc and Nweke I.Nd., 2011.

In Table 2 shown above, there is a reduction in the sperm count of all the patients examined ranging from little reduction to much reduction in the sperm count when pre ivermectin and post ivermectin sperm counts are compared. Also, sperm motility was found to reduce drastically (see Table 3) when pre-ivermectin and post-ivermectin motility tests were compared. Sperm with abnormal morphology were also found to have increased after ivermectin therapy as shown in Table 4 TABLES 3: Results of sperm motility test S/N Pre ivermectin therapy motility (%) 

From Sage Hana: 

Author(s): Idonije O.Ba., Asika E.Cb., Okhiai, Oc and Nweke I.Nd.

The effect of ivermectin, a broad spectrum antihelminthic on the sperm functions of animal models have been extensively studied, however data on humans are very scanty hence this present study.

In this study we screened a total of 385 patients who were diagnosed of onchocerciasis. Out of which, 37 (9.6%) were eligible for further tests, as their sperm counts were normal while the remaining patients had very low sperm counts and were therefore not used for further tests or were too weak after the preliminary screening tests and were not considered eligible for further test/studies.

We therefore investigated the effects of ivermectin therapy on the sperm functions of these eligible 37 diagnosed patients of onchocerciasis who were of ages between 28 and 57 years. The sperm functions were assessed via seminal fluid analysis using standard procedure and the following parameters were measured: sperm counts, sperm motility, sperm morphology, sperm volume, sperm viscosity and sperm liquefaction time.

The above parameters were measured before and after the patients were treated with 150μg/kg body wt of ivermectin for eleven months and the results were compared and also with normal control reference range.

We observed significant reduction in the sperm counts and sperm motility of the patients tested.

On the morphology there was significant increase in the number of abnormal sperm cells. This took the forms of two heads, double tails, white (albino) sperms and extraordinarily large heads. It is suspected that the above alterations in the already determined parameters of the patients’ sperm cells could only have occurred as a result of their treatment with ivermectin.

However, we could not record any significant change or alteration in the sperm viscosity, sperm volume, and sperm liquefaction time of the patients.

We, therefore, suggest that caution be seriously exercised in the treatment of male onchocerciasis patients with ivermectin to avoid the adverse effects it has on the patients’ sperm functions.

Trust the Science!

Monday, July 11, 2022

(TSUNAMI IN) JAPAN, 2011